Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Oct 17;308(15):1573-80.
doi: 10.1001/jama.2012.13043.

Strategies to help a smoker who is struggling to quit

Affiliations
Case Reports

Strategies to help a smoker who is struggling to quit

Nancy A Rigotti. JAMA. .

Abstract

Tobacco use is the leading preventable cause of death worldwide. Stopping tobacco use benefits virtually every smoker. Most of the 19% of US residents who smoke want to quit and have tried to do so. Most individual quit attempts fail, but two-thirds of smokers use no treatment when trying to quit. Treating tobacco dependence is one of the most cost-effective actions in health care. With a brief intervention, physicians can prompt smokers to attempt to quit and connect them to evidence-based treatment that includes pharmacotherapy and behavioral support (ie, counseling). Physicians can link smokers to effective counseling support offered by a free national network of telephone quit lines. Smokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit double their odds of success. The most effective way to use NRT is to combine the long-acting nicotine patch with a shorter-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks. Observational studies have not confirmed case reports of behavior changes associated with varenicline and bupropion, and these drugs' benefits outweigh potential risks. A chronic disease management model is effective for treating tobacco dependence, which deserves as high a priority in health care systems as treating other chronic diseases like diabetes and hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

Dr. Rigotti has received royalties from UpToDate, Inc., and research grants to her institution from Nabi Biopharmaceuticals, Inc., and Pfizer, Inc. She has served as an unpaid consultant for Pfizer, Inc., and Alere Wellbeing, Inc.

Comment in

References

    1. Centers for Disease Control and Prevention. CDC Grand Rounds: Current Opportunities in Tobacco Control. MMWR. 2010;59:487–492. - PubMed
    1. Center for Disease Control and Prevention. Vital signs: Current cigarette smoking among adults aged ≥18 years — United states, 2005–2010. MMWR. 2011;60:1–5. - PubMed
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004:1–9. - PMC - PubMed
    1. Center for Disease Control and Prevention. Quitting Smoking Among Adults --- United States, 2001—2010. MMWR. 2011;60:1513–1519. - PubMed
    1. Fiore MC, Jaen CR, Baker TB, et al. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008. May, Treating Tobacco Use and Dependence: 2008 Update.

Publication types

MeSH terms